# SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction

> **NCT00490594** · PHASE1 · UNKNOWN · sponsor: **Serica Technologies, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Anterior Cruciate Ligament
- Knee Injuries

## Interventions

- **DEVICE:** ACL Reconstruction (SeriACL™ Device)

## Key facts

- **NCT ID:** NCT00490594
- **Lead sponsor:** Serica Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-06
- **Primary completion:** 2008-10
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2008-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00490594

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00490594, "SeriACL™ Device Trial for Anterior Cruciate Ligament (ACL) Reconstruction". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00490594. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*